Rejuvenate Biomed Started a Groundbreaking Clinical Trial and Expands for Future Growth
Rejuvenate Biomed initiated first-of-its-kind clinical trial with a combination drug for age-related diseases. DIEPENBEEK, HEALTH CAMPUS, BELGIUM, March 29, 2022 /EINPresswire.com/ — Rejuvenate Biomed NV (“Rejuvenate”), a biomedical company developing novel combination drugs for age-related diseases, today provides an update on its development pipeline and strategy. Rejuvenate has commenced its first Phase 1 clinical trial […]